Certain chronic comorbidities, including diabetes, are highly prevalent in people with
coronavirus disease 2019 (COVID-19) and are associated with an increased risk of severe …

Abstract Background and Aims Post Covid-19 syndrome (PCS) is a major cause of
morbidity. In this article we intend to review the association and consequences of PCS and …

COVID-19 has expanded across the world since its discovery in Wuhan (China) and has
had a significant impact on people's lives and health. Long COVID is a term coined by the …

The impact of the COVID-19 lockdown on glycaemic control and other metabolic parameters
in patients with type 2 diabetes is still evolving. Aim: This systematic review and meta …

The advent and rapid spread of the coronavirus disease-2019 (COVID19) pandemic across
the world has focused attention on the relationship of commonly occurring comorbidities …

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) virus, is a global pandemic impacting 254 million people in …

Introduction The COVID-19 pandemic disproportionately affected patients who had
comorbid diabetes mellitus. COVID-19 patients with diabetes experience significantly higher …

Background and aims We aimed to study newly diagnosed diabetes in patients with mild to
moderate COVID-19. Methods This was a retrospective cohort study of COVID-19 patients …

Evidence suggests associations between COVID-19 patients or vaccines and
glycometabolic dysfunction and an even higher risk of the occurrence of diabetes. Herein …

Aims High rates of newly diagnosed diabetes mellitus (NDDM) have been reported in
association with coronavirus disease-2019 (COVID-19). Factors associated with NDDM and …